Pharmac and AstraZeneca clash over omeprazole substitution
This article was originally published in Scrip
Executive Summary
New Zealand's pharmaceutical management agency Pharmachas accused AstraZenecaof "scaremongering" to persuade people to continue using its previously funded proton pump inhibitor Losec (omeprazole).